Back to Agenda
Session 2 - Transparency in clinical trials
Session Chair(s)
Marianne Lunzer, DrMed
Assessor, Dept of Clinical Trials, Federal Office for Safety in Health Care
AGES, Austria
Francesca Scotti
Scientific Specialist
European Medicines Agency, Netherlands
Transparency in Clinical Trials
Speaker(s)
Overview of new transparency rules
Francesca Scotti
European Medicines Agency, Netherlands
Scientific Specialist
Demonstration of the new Public Portal
Charalampos Drosos
European Medicines Agency, Netherlands
CTIS Change Management Officer, Data Analytics and Methods Task Force
New Transparency rules –How to manage from a commercial Sponsors’ Perspective
Polyana Bastos
Actelion Pharmaceuticals, Switzerland
New Transparency rules –How to manage from a non-commercial Sponsors’ Perspective
Andrea Seidel-Glaetzer, MA, RN
Coordination Centre For Clinical Trials Heidelberg (KKS), Germany
Head of Project Management
Have an account?